Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC regarding Forxiga (dapagliflozin) 5mg: should no longer be used for the treatment of Type 1 Diabetes Mellitus
Important Safety Information – Forxiga (dapagliflozin) 5mg